New process allows labs to use same Pap test vial instead of transferring sample to new vial, thus simplifying workflow INDIANAPOLIS, June 26, 2013 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) ...

Basel, 16 June 2022 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the launch of a human papillomavirus (HPV) self sampling solution in countries accepting the CE mark. This new solution enables ...

Introduction Self-sampling for cervical cancer screening is a promising strategy to improve coverage and reduce strain on ...

A test that can detect the DNA of the human papilloma virus (HPV), to confirm the need for cervical cancer screening in women 25 years and older, has gained the FDA’s support as a primary screening ...

The first shipments of self-collection HPV tests for cervical cancer screening are making their way to labs and health care facilities across the United States. The Food and Drug Administration gave ...

The cobas HPV test detects DNA from 14 high-risk HPV types using a sample of cervical cells, according to the FDA. The test specifically identifies HPV type 16 (HPV16) and HPV type 18 (HPV18), while ...

Roche Diagnostics is looking to a new screening tool to help women learn in a more private way if they are at increased risk for cervical cancer—a self-collection test to identify HPV. With the test, ...

More than 99 percent of cervical cancers are caused by persistent high-risk HPV infection 1 Cervical cancer is nearly 100 percent preventable with proper HPV vaccination, screening and treatment; ...